Rocky Brands Q1 2026 Earnings EPS Miss Sends Stock Lower TSHA Q1 2026 Earnings EPS Miss Highlights Ongoing DevelopmentStage Challenges MGEE Q1 2026 Earnings EPS Surges Past Estimates on Strong Operational Performance NRX Pharmaceuticals Q1 2026 Earnings Wider Loss Despite No Revenue Stock Advances SOPH Q1 2026 Earnings EPS Misses Estimates as Revenue Remains Undisclosed BeyondSpring Q1 2026 Earnings Narrowed Loss Per Share and Positive Stock Movement